Cytokine profiles in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy
- PMID: 16369449
- PMCID: PMC1681548
Cytokine profiles in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy
Abstract
Context: There have been few longitudinal studies of cytokine production in neonatally acquired HIV-1 infection and none in Asian or Chinese children.
Objective: To determine whether monitoring cytokine production could contribute to the better management of pediatric patients with HIV-1 infection.
Setting: Clinical Immunology Laboratory and Pediatrics Department, University Hospital, Hong Kong.
Patients: Ten Asian and 2 Eurasian children infected with HIV-1 by mother-to-child transmission were followed for up to 5 years while on treatment with highly active antiretroviral therapy (HAART).
Main outcome measures: Numbers of unstimulated and mitogen-activated cytokine-secreting cells (IFN-gamma, interleukin [IL]-2, IL-4, IL-6, IL-10, IL-12, and TNF-alpha) were measured by ELISPOT assay at frequent intervals, and correlations were sought with CD4+ and CD8+ cell counts and viral loads.
Results: Mitogen-stimulated IL-2-secreting cells were directly associated with recovery of CD4+ cells. Correlations with viral load were found for Con A-induced IFN-gamma, Con A-induced IL-4, and unstimulated IL-10, suggesting that these cytokines were either suppressed by high virus levels or that higher cytokine levels suppressed virus. IFN-gamma, IL-2-, IL-4-, and IL-12-secreting cells induced by PHA, Con A, and/or SAC tended to increase for the first 3-4 years of treatment but declined thereafter.
Conclusions: Alterations in cytokine profiles were not associated with adverse clinical events and there was little evidence to indicate that monitoring cytokine enzyme-linked immunospots (ELISPOTs) could contribute to pediatric patient management.
Figures




References
-
- Mocroft A, Katlama C, Johnson AM, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet. 2003;362:22–29. - PubMed
-
- Anton PA, Mitsuyasu RT, Deeks SG, et al. Multiple measures of HIV burden in blood and tissues are correlated with each other but not with clinical parameters in aviremic subjects. AIDS. 2003;17:53–63. - PubMed
-
- Mansky LM. HIV mutagenesis and the evolution of antiretroviral drug resistance. Drug Resist Updat. 2002;5:219–223. - PubMed
-
- Anthony KB, Yoder C, Metcalf JA, et al. Incomplete T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover. J AIDS. 2003;33:125–133. - PubMed
-
- Yoshioka M, Bradley WG, Shapshak P, et al. Role of immune activation and cytokine expression in HIV-1 associated neurological disease. Adv Neuroimmunol. 1995;5:335–358. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials